RGD peptidePrice The RGD peptide, characterized by the amino acid sequence Arginine-Glycine-Aspartate (Arg-Gly-Asp), has emerged as a significant player in biological research and therapeutic development, primarily due to its potent integrin inhibitor capabilities. Integrins are a crucial family of cell surface receptors that mediate cell-to-extracellular matrix (ECM) and cell-to-cell adhesion. The RGD motif is a well-established cell adhesion sequence found in various ECM proteins, serving as a key binding site for specific integrins. Consequently, synthetic RGD peptides have been extensively utilized as tools to study and inhibit integrin-ligand interactions.
The fundamental mechanism by which RGD peptides function is through competitive binding. They mimic the natural RGD sequence present in ligands like fibronectin and vitronectin, thereby competitively inhibiting the binding of these ligands to integrin receptorsRGD peptide(GRGDNP) ...RGD peptide(GRGDNP) acts as aninhibitorofintegrin-ligand interactions and plays an important role in cell adhesion, migration, growth .... This inhibition disrupts the signaling pathways initiated by integrin engagement, affecting critical cellular processes such as cell adhesion, migration, proliferation, and survival. For instance, the RGD peptide (GRGDNP) is a well-characterized integrin inhibitor that competitively blocks the binding of α5β1 integrin to the ECM, thereby modulating cellular responses.
The therapeutic potential of RGD peptides as integrin inhibitors is particularly pronounced in fields like oncology and regenerative medicine. In cancer, integrins such as αvβ3 and αvβ5 are often overexpressed on tumor cells and tumor vasculature, playing a vital role in tumor growth, angiogenesis (the formation of new blood vessels), invasion, and metastasis. By targeting these integrins, RGD peptides can be engineered to specifically target cancer cells and their surrounding microenvironmentAn Inhibitor of a Cell Adhesion Receptor Stimulates .... This targeted approach can lead to improved drug delivery efficiency by enhancing the accumulation of therapeutic agents at the tumor site, as demonstrated in studies involving RGD-decorated nanoparticles.An Inhibitor of a Cell Adhesion Receptor Stimulates ... Furthermore, the inhibition of αvβ3 integrin by RGD-containing peptides has shown promise in retarding tumor growth and reducing metastasis.
Beyond cancer therapy, RGD peptides are also explored for their role in various other conditions. For example, the RGD peptide has been investigated for its ability to reverse immunosuppression in certain contexts. Its application in directing the association of various cell types with diverse biomaterials highlights its utility in tissue engineering and regenerative medicine, where controlled cell adhesion is paramountRGD peptide(GRGDNP) is aninhibitorofintegrin-ligand interactions, competitively inhibiting the binding of α5β1 to the extracellular matrix (ECM).. The functionality of RGD peptides is typically maintained throughout these applications, making them versatile tools.Inhibition of integrin function by a cyclic RGD-containing ...
The development of RGD peptide-based inhibitors is an active area of research. While linear RGD peptides are effective, cyclic RGD peptides often exhibit enhanced binding affinity and stability. Novel cyclic RGD peptides, such as those based on cilengitide, have been developed as potent inhibitors of specific integrin subtypes like αvβ3 integrin protein. Research into structure-activity relationships of RGD-containing peptides continues to refine their design for improved potency and selectivity. This includes exploring modifications like N-methylation to create highly active and selective integrin inhibitorsRGD peptide(GRGDNP) ...RGD peptide(GRGDNP) acts as aninhibitorofintegrin-ligand interactions and plays an important role in cell adhesion, migration, growth ....
It is important to note that while RGD peptides are powerful integrin inhibitors, their efficacy and specificity can vary depending on the integrin subtype and the specific context of their application. For instance, the ability of an RGD peptide to completely inhibit integrin function can depend on the specific integrin-ligand interaction being studied.RGD-decorated nanoparticles: Therapeutic potential beyond cancer Studies on RGD peptide binding specificity to integrin subtypes are crucial for optimizing their therapeutic use.
In summary, the RGD peptide is a fundamental integrin inhibitor with broad applications. Its ability to mimic natural ligands and competitively bind to integrins underpins its utility in research and its potential as a therapeutic agent. From disrupting cancer progression by targeting tumor vasculature to facilitating cell adhesion in regenerative medicine, the RGD peptide and its derivatives represent a significant advancement in our understanding and manipulation of integrin biology作者:H Javid·2024·被引用次数:194—RGD peptidescan be utilized to specifically target cancer cells and the tumor vasculature by engaging with theseintegrins, improving drug delivery efficiency.. The ongoing exploration of RGD peptides and other integrin inhibitors promises further breakthroughs in addressing a range of challenging diseases.GRGDSP, a synthetic linearRGD peptide, is anintegrin inhibitor. - Mechanism of Action & Protocol.
Join the newsletter to receive news, updates, new products and freebies in your inbox.